Leukemic Stem Cells Lscs | List of Frontiers open access articles

Review

Published on 13 May 2021

Combination Therapies in Chronic Myeloid Leukemia for Potential Treatment-Free Remission: Focus on Leukemia Stem Cells and Immune Modulation

in Hematologic Malignancies

Hui Mu
Xiaojian Zhu
Hui Jia
Lu Zhou
Hong Liu

Frontiers in Oncology

doi 10.3389/fonc.2021.643382

119,351 views
36 citations

Mini Review

Published on 29 Apr 2021

Taming Cell-to-Cell Heterogeneity in Acute Myeloid Leukaemia With Machine Learning

in Hematologic Malignancies

Yara E. Sánchez-Corrales
Ruben V. C. Pohle
Sergi Castellano
Alice Giustacchini

Frontiers in Oncology

doi 10.3389/fonc.2021.666829

8,336 views
4 citations

Mini Review

Published on 12 Nov 2021

Adhesion Molecules Involved in Stem Cell Niche Retention During Normal Haematopoiesis and in Acute Myeloid Leukaemia

in Comparative Immunology

Julien M. P. Grenier
Céline Testut
Cyril Fauriat
Stéphane J. C. Mancini
Michel Aurrand-Lions

Frontiers in Immunology

doi 10.3389/fimmu.2021.756231

10,835 views
23 citations

Original Research

Published on 19 Nov 2024

Targeting autophagy: polydatin’s role in inducing cell death in AML

in Pharmacology of Anti-Cancer Drugs

Ping Fu
Qing Luo
Chao Wang
Liping Chen
Chang Dong
Ke Yang
Guang Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1470217

2,120 views
6 citations

Review

Published on 18 May 2018

Therapeutic Antibodies for Myeloid Neoplasms—Current Developments and Future Directions

in Pharmacology of Anti-Cancer Drugs

Christian M. Schürch

Frontiers in Oncology

doi 10.3389/fonc.2018.00152

16,506 views
39 citations

Review

Published on 10 Dec 2025

Flow cytometric detection of leukemic stem cells in Acute Myeloid Leukemia: current status and future directions

in Pharmacology of Anti-Cancer Drugs

Mariam M. Youssef
Christopher Y. Park

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1724473

2,093 views

Mini Review

Published on 24 Jun 2022

Leukemic Stem Cell: A Mini-Review on Clinical Perspectives

in Pharmacology of Anti-Cancer Drugs

Igor Valentim Barreto
Flávia Melo Cunha de Pinho Pessoa
Caio Bezerra Machado
Laudreísa da Costa Pantoja
Rodrigo Monteiro Ribeiro
Germison Silva Lopes
Maria Elisabete Amaral de Moraes
Manoel Odorico de Moraes Filho
Lucas Eduardo Botelho de Souza
Rommel Mário Rodriguez Burbano

Frontiers in Oncology

doi 10.3389/fonc.2022.931050

8,821 views
14 citations

Review

Published on 20 Mar 2024

Inflammation as a driver of hematological malignancies

in Hematologic Malignancies

Sumedha Saluja
Ishu Bansal
Ruchi Bhardwaj
Mohammad Sabique Beg
Jayanth Kumar Palanichamy

Frontiers in Oncology

doi 10.3389/fonc.2024.1347402

9,235 views
23 citations

Mini Review

Published on 15 Oct 2021

Leukemic Stem Cells: From Leukemic Niche Biology to Treatment Opportunities

in Cytokines and Soluble Mediators in Immunity

Tony Marchand
Sandra Pinho

Frontiers in Immunology

doi 10.3389/fimmu.2021.775128

24,711 views
72 citations

Original Research

Published on 30 May 2018

Residual Peripheral Blood CD26+ Leukemic Stem Cells in Chronic Myeloid Leukemia Patients During TKI Therapy and During Treatment-Free Remission

in Hematologic Malignancies

Monica Bocchia
Anna Sicuranza
Elisabetta Abruzzese
Alessandra Iurlo
Santina Sirianni
Antonella Gozzini
Sara Galimberti
Lara Aprile
Bruno Martino
Patrizia Pregno

Frontiers in Oncology

doi 10.3389/fonc.2018.00194

10,343 views
99 citations

Original Research

Published on 04 Jul 2023

Myelofibrosis at diagnosis is associated with the failure of treatment-free remission in CML patients

in Pharmacology of Anti-Cancer Drugs

Henrike Jacobi
Margherita Vieri
Marlena Bütow
Carolina Y. Namasu
Laura Flüter
Ivan G. Costa
Tiago Maié
Katharina Lindemann-Docter
Nicolas Chatain
Fabian Beier

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1212392

6,934 views
7 citations

Articles

Combination Therapies in Chronic Myeloid Leukemia for Potential Treatment-Free Remission: Focus on Leukemia Stem Cells and Immune Modulation

Taming Cell-to-Cell Heterogeneity in Acute Myeloid Leukaemia With Machine Learning

Adhesion Molecules Involved in Stem Cell Niche Retention During Normal Haematopoiesis and in Acute Myeloid Leukaemia

Targeting autophagy: polydatin’s role in inducing cell death in AML

Therapeutic Antibodies for Myeloid Neoplasms—Current Developments and Future Directions

Flow cytometric detection of leukemic stem cells in Acute Myeloid Leukemia: current status and future directions

Leukemic Stem Cell: A Mini-Review on Clinical Perspectives

Inflammation as a driver of hematological malignancies

Leukemic Stem Cells: From Leukemic Niche Biology to Treatment Opportunities

Residual Peripheral Blood CD26+ Leukemic Stem Cells in Chronic Myeloid Leukemia Patients During TKI Therapy and During Treatment-Free Remission

Myelofibrosis at diagnosis is associated with the failure of treatment-free remission in CML patients